Home › Calculator › MLTX Dividend Calculator 2026
MLTX Dividend Calculator 2026
No dividendHealthcareMoonLake Immunotherapeutics · NASDAQ
Price: $11.85 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
MLTX is not a dividend-focused stock
MLTX pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
MLTX Dividend Yield
MoonLake Immunotherapeutics (MLTX) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MLTX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About MoonLake Immunotherapeutics (MLTX) — Dividend Analysis 2026
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
MLTX Dividend & DRIP — Frequently Asked Questions
Does MLTX pay a dividend?
No. MoonLake Immunotherapeutics (MLTX) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of MLTX?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does MLTX have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. MLTX has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to MLTX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MLTX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MLTX position with:
🌍 MLTX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MLTX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MLTX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MLTX Dividend Payment Schedule
MLTX pays quarterly — 4 times per year. Ex-div: —.
📊 MLTX vs Healthcare Benchmarks
How MLTX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MLTX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MLTX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-07-27 | 1,100 | $20.00 | $22.0K | ||
| Sale | 2026-07-21 | 50,000 | $20.02 | $1.00M | ||
| Sale | 2026-07-22 | 2,448 | $20.00 | $49.0K | ||
| Sale | 2026-07-20 | 43,700 | $20.09 | $877.9K | ||
| Sale | 2026-07-15 | 16,105 | $20.01 | $322.3K | ||
| Sale | 2026-07-09 | 33,936 | $20.01 | $679.1K | ||
| Sale | 2026-07-10 | 68,289 | $20.02 | $1.37M | ||
| Sale | 2026-07-01 | 47,775 | $20.03 | $956.9K | ||
| Sale | 2026-06-22 | 39,120 | $22.04 | $862.2K | ||
| A-Award | 2026-06-17 | 22,195 | $19.19 | $425.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare MLTX with peers: MLTX vs ABSI · MLTX vs AVBP · MLTX vs CTMX
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MLTX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
MoonLake Immunotherapeutics (MLTX) is currently trading at $11.85, 49% below its 52-week high. It does not currently pay a regular dividend.
Does MLTX Pay a Dividend? MoonLake Immunotherapeutics Dividend Status
MoonLake Immunotherapeutics (MLTX) is a healthcare stock trading at $11.85. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MLTX News
LiveProjected your MLTX DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.